Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
2000 1
2005 1
2009 1
2010 1
2011 1
2012 1
2014 5
2015 3
2016 10
2017 3
2018 6
2019 9
2020 10
2021 10
2022 6
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Hetero-bivalent agents targeting FAP and PSMA.
Boinapally S, Lisok A, Lofland G, Minn I, Yan Y, Jiang Z, Shin MJ, Merino VF, Zheng L, Brayton C, Pomper MG, Banerjee SR. Boinapally S, et al. Among authors: minn i. Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4369-4381. doi: 10.1007/s00259-022-05933-3. Epub 2022 Aug 15. Eur J Nucl Med Mol Imaging. 2022. PMID: 35965291
Molecular-genetic imaging of cancer.
Minn I, Menezes ME, Sarkar S, Yarlagadda K, Das SK, Emdad L, Sarkar D, Fisher PB, Pomper MG. Minn I, et al. Adv Cancer Res. 2014;124:131-69. doi: 10.1016/B978-0-12-411638-2.00004-5. Adv Cancer Res. 2014. PMID: 25287688 Free PMC article. Review.
An Improved 211At-Labeled Agent for PSMA-Targeted α-Therapy.
Mease RC, Kang CM, Kumar V, Banerjee SR, Minn I, Brummet M, Gabrielson KL, Feng Y, Park A, Kiess AP, Sgouros G, Vaidyanathan G, Zalutsky MR, Pomper MG. Mease RC, et al. Among authors: minn i. J Nucl Med. 2022 Feb;63(2):259-267. doi: 10.2967/jnumed.121.262098. Epub 2021 Jun 4. J Nucl Med. 2022. PMID: 34088772 Free PMC article.
Detecting Tumor Metastases: The Road to Therapy Starts Here.
Menezes ME, Das SK, Minn I, Emdad L, Wang XY, Sarkar D, Pomper MG, Fisher PB. Menezes ME, et al. Among authors: minn i. Adv Cancer Res. 2016;132:1-44. doi: 10.1016/bs.acr.2016.07.001. Epub 2016 Aug 17. Adv Cancer Res. 2016. PMID: 27613128 Free PMC article. Review.
A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents.
Chen Y, Minn I, Rowe SP, Lisok A, Chatterjee S, Brummet M, Banerjee SR, Mease RC, Pomper MG. Chen Y, et al. Among authors: minn i. Biomolecules. 2022 Mar 5;12(3):405. doi: 10.3390/biom12030405. Biomolecules. 2022. PMID: 35327597 Free PMC article.
Imaging Brain Injury in Former National Football League Players.
Rubin LH, Du Y, Sweeney SE, O'Toole R, Thomas CL, Zandi AG, Shinehouse LK, Brosnan MK, Nam H, Burke ME, Bureau SC, Kilgore JJ, Yoon M, Soule AR, Lesniak WG, Minn I, Rowe SP, Holt DP, Hall AW, Mathews WB, Smith GS, Nowinski CJ, Kassiou M, Dannals RF, Pomper MG, Coughlin JM. Rubin LH, et al. Among authors: minn i. JAMA Netw Open. 2023 Oct 2;6(10):e2340580. doi: 10.1001/jamanetworkopen.2023.40580. JAMA Netw Open. 2023. PMID: 37902750 Free PMC article.
Correction to: Hetero-bivalent agents targeting FAP and PSMA.
Boinapally S, Lisok A, Lofland G, Minn I, Yan Y, Jiang Z, Shin MJ, Merino VF, Zheng L, Brayton C, Pomper MG, Banerjee SR. Boinapally S, et al. Among authors: minn i. Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4755. doi: 10.1007/s00259-022-05951-1. Eur J Nucl Med Mol Imaging. 2022. PMID: 36044067 No abstract available.
66 results